Evidence map›Paper›PMID 21866423›Full record

ArticleCellular & molecular biology letters2011

Non-erythroid beta spectrin interacting proteins and their effects on spectrin tetramerization.

Akin Sevinc, Leslie W-M Fung

Abstract read
In one paragraph

Article in Cellular & molecular biology letters, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Akin SevincDepartment of Chemistry, University of Illinois at Chicago, 845 W. Taylor Street, MC 111, Chicago, IL 60607, USA.
Leslie W-M Fung

Funding

Assembly of Spectrin IsoformsR01GM068621 · NIGMS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI FUNG, LESLIE W. · 2003 to 2009
$1.5M
NIGMS NIH HHS GM68621NIGMS NIH HHS R01 GM068621
6 · The paper itself

Abstract

With yeast two-hybrid methods, we used a C-terminal fragment (residues 1697-2145) of non-erythroid beta spectrin (βII-C), including the region involved in the association with alpha spectrin to form tetramers, as the bait to screen a human brain cDNA library to identify proteins interacting with βII-C. We applied stringent selection steps to eliminate false positives and identified 17 proteins that interacted with βII-C (IP(βII-C) s). The proteins include a fragment (residues 38-284) of "THAP domain containing, apoptosis associated protein 3, isoform CRA g", "glioma tumor suppressor candidate region gene 2" (residues 1-478), a fragment (residues 74-442) of septin 8 isoform c, a fragment (residues 704-953) of "coatomer protein complex, subunit beta 1, a fragment (residues 146-614) of zinc-finger protein 251, and a fragment (residues 284-435) of syntaxin binding protein 1. We used yeast three-hybrid system to determine the effects of these βII-C interacting proteins as well as of 7 proteins previously identified to interact with the tetramerization region of non-erythroid alpha spectrin (IP(αII-N) s) [1] on spectrin tetramer formation. The results showed that 3 IP(βII-C) s were able to bind βII-C even in the presence of αII-N, and 4 IP(αII-N) s were able to bind αII-N in the presence of βII-C. We also found that the syntaxin binding protein 1 fragment abolished αII-N and βII-C interaction, suggesting that this protein may inhibit or regulate non-erythroid spectrin tetramer formation.

Indexed as

Binding SitesBrainCarrier ProteinsCell LineCytoskeletonGene LibraryHumansMicrofilament ProteinsModels, MolecularNeuronsPeptide FragmentsPlasmidsPolymerizationProtein BindingProtein IsoformsProtein Structure, TertiaryCarrier ProteinsMicrofilament ProteinsPeptide FragmentsProtein IsoformsRecombinant ProteinsSpectrin

Identifiers

PMID21866423
PMCPMC3675649

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.